Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-25T09:43:41.617Z Has data issue: false hasContentIssue false

29 - Pharmacogenetics and mood disorders

from Section 5 - The promise of biomarkers and response prediction

Published online by Cambridge University Press:  05 May 2013

By
Gonzalo Laje  and
Francis J. McMahon
Edited by
J. John Mann
Edited in association with
Patrick J. McGrath  and
Steven P. Roose
J. John Mann
Affiliation:
Columbia University, New York
Patrick J. McGrath
Affiliation:
Columbia University, New York
Steven P. Roose
Affiliation:
Columbia University, New York
Get access

Summary

This chapter reviews some of the key considerations of pharmacogenetics in the treatment of mood disorders. There have been a number of small studies aimed at finding genetic markers of antidepressant treatment outcome. If the serotonin transporter (SLC6A4) is the most studied gene in psychiatry, a functional polymorphism in its promoter region (known as the linked polymorphic region (LPR)), is the most studied genetic marker. Variation in brain-derived neurotrophic factor (BDNF) has been thought to play a role in the etiology of affective disorders and the mediation of antidepressant treatment response. Genome-wide association studies (GWAS) are a relatively new kind of genetic study that take advantage of large numbers of highly informative genetic markers, spread across each chromosome. Adverse events occur with all pharmacological treatments. Two groups of antidepressant-associated adverse events have been studied in large samples: treatment-emergent suicidal ideation (TESI) and sexual dysfunction (SD).
Type
Chapter
Information
Clinical Handbook for the Management of Mood Disorders , pp. 368 - 379
Publisher: Cambridge University Press
Print publication year: 2013

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Save book to Kindle

To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×